Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series

Edoardo Marrani (Corresponding Author), Valeria Paganelli, Cinzia de Libero, Rolando Cimaz, Gabriele Simonini

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)


BACKGROUND: Non-infectious uveitis represents one of the most common causes of blindness, even at pediatric age; in particular, idiopathic chronic uveitis can pose significant difficulties during treatment, due to a partial response to TNF-α antagonists. To date, very few case series exist describing the treatment of idiopathic uveitis not adequately controlled by TNF-α antagonists. The aim of our study is to describe the role of abatacept in achieving remission in patients with idiopathic uveitis previously treated with TNF-α antagonists, and to assess how long abatacept efficacy is maintained during follow-up. The treatment's safety profile and tolerability were also specifically investigated.

METHODS: Three patients affected with chronic idiopathic uveitis, who have been treated with abatacept due to loss of efficacy of TNF-α antagonists, were reviewed. Details of the demographic and clinical characteristics were recorded, and a summary of the medical history was obtained. Patients were regularly reviewed in the ophthalmology and rheumatology clinics. Assessment of their ocular condition was characterized according to the Standardization of Uveitis Nomenclature (SUN) group.

RESULTS: In our patients, abatacept was able to induce remission and to discontinue systemic corticosteroids after a mean of 30 weeks; the drug maintained its efficacy through a long follow-up period (42, 33, and 18 months respectively), with an excellent safety profile.

CONCLUSION: Our small case series seems to suggest abatacept to be a promising therapy in children affected with chronic idiopathic uveitis not adequately controlled by TNF-α antagonists.

Original languageEnglish
Pages (from-to)1813-1816
Number of pages4
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Issue number10
Early online date27 Aug 2015
Publication statusPublished - Oct 2015

Bibliographical note

We thanks Dr Roberto Caputo, Head of the Ophthalmology Department in Anna Meyer Children Hospital, for critically reviewing the manuscript.


  • Abatacept
  • Adolescent
  • Chronic Disease
  • Drug Combinations
  • Female
  • Follow-Up Studies
  • Glucocorticoids
  • Humans
  • Immunosuppressive Agents
  • Male
  • Methotrexate
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha
  • Uveitis
  • Young Adult
  • Case Reports
  • Journal Article


Dive into the research topics of 'Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series'. Together they form a unique fingerprint.

Cite this